“Use of low-dose tacrolimus and associated hypomagnesemia in the prevention of erectile dysfunction following prostatectomy for prostate cancer.”, Pharmacol Rep, vol. 68, no. 6, pp. 1154-1158, 2016.
, , “Use of Opportunistic Clinical Data and a Population Pharmacokinetic Model to Support Dosing of Clindamycin for Premature Infants to Adolescents”, Clin Pharmacol Ther, vol. 96, pp. 429-437, 2014.
, “Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescents.”, Clin Pharmacol Ther, vol. 96, no. 4, pp. 429-37, 2014.
, “Use of Population Modeling to Characterize the Pharmacokinetics of Oxcarbazepine And Its Metabolite in Children and Adolescents with Obesity”, in Annual Meeting of American Society for Clinical Pharmacology and Therapeutics (ASCPT), Virtual, 2022.
, “Use of rhGH in children with chronic kidney disease: lessons from NAPRTCS.”, Pediatr Nephrol, vol. 22, no. 8, pp. 1195-204, 2007.
, “Use of rhGH in Children with Chronic Kidney Disease: Lessons from NAPRTCS”, Pediatr Nephrol, vol. 22, pp. 1195-1204, 2007.
, “Use of the National Cancer Institute Community Cancer Centers Program Screening and Accrual Log to Address Cancer Clinical Trial Accrual”, J Oncol Pract, vol. 10, pp. e73-e80, 2014.
, “Use of the National Cancer Institute Community Cancer Centers Program screening and accrual log to address cancer clinical trial accrual.”, J Oncol Pract, vol. 10, no. 2, pp. e73-80, 2014.
, “Usefulness of the Atrial Emptying Fraction to Predict Maintenance of Sinus Rhythm After Direct Current Cardioversion for Atrial Fibrillation.”, Am J Cardiol, vol. 118, no. 9, pp. 1345-1349, 2016.
, “Using cross-validation to evaluate predictive accuracy of survival risk classifiers based on high-dimensional data.”, Brief Bioinform, vol. 12, no. 3, pp. 203-14, 2011.
, “Using Cross-Validation to Evaluate Predictive Accuracy of Survival Risk Classifiers Based on High-Dimensional Data”, Brief Bioinformatics, vol. 12, pp. 203-214, 2011.
, “Using electronic health record data for substance use Screening, Brief Intervention, and Referral to Treatment among adults with type 2 diabetes: Design of a National Drug Abuse Treatment Clinical Trials Network study.”, Contemp Clin Trials, vol. 46, pp. 30-38, 2016.
, “Using Good Clinical Practice in Ophthalmic Photography: The Clinical Research Organization's Role in Ophthalmic Photography”, in Ophthalmic Photographers' Society, Bethesda, MD, 2007.
, , “Utility of Targeted Gene Sequencing to Differentiate Myeloid Malignancies from other Cytopenic Conditions”, Blood Adv, 2023.
, “Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder.”, J Addict Med, vol. 10, no. 4, pp. 236-43, 2016.
, , “Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine”, J Amer Med Assn, vol. 292, pp. 1205-1212, 2004.
, “Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine: a randomized controlled trial.”, JAMA, vol. 292, no. 10, pp. 1205-12, 2004.
, “Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.”, N Engl J Med, vol. 361, no. 23, pp. 2209-20, 2009.
, “Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand”, N Engl J Med, vol. 361, pp. 2209-2220, 2009.
, “Vaccine Protection Against Acquisition of Neutralization-Resistant SIV Challenges in Rhesus Monkeys”, Nature, vol. 482, pp. 89-93, 2012.
, “Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys.”, Nature, vol. 482, no. 7383, pp. 89-93, 2012.
, “A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trials.”, Sci Transl Med, vol. 11, no. 507, 2019.
,